Tandem Diabetes Care TNDM Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tandem Diabetes Care's investing cash flow?
- Tandem Diabetes Care (TNDM) reported investing cash flow of -$195.45M in Q1 2026.
- How has Tandem Diabetes Care's investing cash flow changed year-over-year?
- Tandem Diabetes Care's investing cash flow decreased by 2227.7% year-over-year, from $9.19M to -$195.45M.
- What is the long-term trend for Tandem Diabetes Care's investing cash flow?
- Over 2 years (2021 to 2023), Tandem Diabetes Care's investing cash flow has grown at a -30.1% compound annual growth rate (CAGR), from -$186.88M to -$91.44M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.